Physician profile
David Bethune
NPI 1437156221
$100,977.73
in general payments reported to CMS, 2019-2025
8 companies · $40K in 2025
The $40K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $886 · 2020: $373 · 2021: $20K · 2022: $4,119 · 2023: $9,414 · 2024: $26K · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $72K · Travel and Lodging: $2,467 · Food and Beverage: $927 · Gift: $58.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $72,110.57 |
| Travel and Lodging | $2,467.44 |
| Food and Beverage | $927.00 |
| Gift | $58.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shoulder Innovations, INC. | $85,623.88 | 2019-2025 | Inset System |
| Genesis Software Innovations, LLC | $15,243.15 | 2021-2025 | |
| Stryker Corporation | $26.71 | 2022-2023 | Aequalis Flex Revive |
| Solventum Corporation | $23.23 | 2024 | Prevena |
| Sanara Medtech INC. | $17.48 | 2023 | Celleraterx |
| Biotissue Holdings INC. | $16.67 | 2023 | |
| Cornerstone Medical Associates, INC. | $14.91 | 2025 | |
| Ferring Pharmaceuticals INC. | $11.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$231,508.06 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bethune listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.